News
BigHat Biosciences is adding Synaffix’s antibody-drug conjugate (ADC) tech to its wardrobe, pairing the science with its antibody design platform to tailor a next-gen ADC pipeline. BigHat used its AI- ...
Lotte Biologics Co. Ltd. said it partnered with domestic bioventure Kanaph Therapeutics Inc. to develop an antibody-drug conjugate (ADC) technology platform in hopes of rounding out a full, in-house ...
BioWorld - Thursday, August 14, 2025 See today's BioWorld See today's BioWorld Asia Home » Building CDMO reach, Lotte Biologics partners with Kanaph for ADC-tech platform To read the full story, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback